OR WAIT null SECS
March 07, 2018
With minimal damage to its manufacturing plant in Humacao, Puerto Rico, Colorcon has been able to restore full operations.
March 06, 2018
The pharma major will spin out six molecules in early stage inflammation and autoimmune programs into a new company called Viela Bio.
February 09, 2018
The acquisition strengthens an already existing collaboration between the companies to advance clinical development of therapies across multiple drug categories.
February 07, 2018
Through its Janssen pharmaceutical companies, Johnson & Johnson, has partnered with Theravance to develop and commercialize a therapeutic for inflammatory bowel diseases.
February 06, 2018
Amgen plans to invest approximately $300 million in a new biomanufacturing plant in the United States.
February 02, 2018
Hospitals form not-for-profit drug company to combat drug shortages and high prices.
January 30, 2018
The acquisition will strengthen Sanofi's R&D strategy and expands its franchise for rare blood disorders.
January 24, 2018
The acquisition builds on the companies' earlier collaboration to develop T-cell-based therapeutics.
January 19, 2018
Frustrated with chronic shortages and high costs, hospitals form their own generic drug company.
January 16, 2018
The acquisition strengthens Charles River Laboratories’ capabilities in the oncology and immunology therapeutic areas.